Kovačević Marijana, Mališ Snežana, Pavlović Dragana, Kovačević Maksim, Savić Radojević Ana, Djukanović Ljubica
University of East Sarajevo, Faculty of Medicine, Foča, Bosnia and Herzegovina.
Department for Internal Medicine, University Hospital, Foča, Bosnia and Herzegovina.
Int Urol Nephrol. 2022 Jun;54(6):1365-1372. doi: 10.1007/s11255-021-03031-1. Epub 2021 Oct 16.
The aim of the study was to examine whether biomarkers of oxidative stress are predictors of diabetic nephropathy (DN) progression.
The study involved 45 patients with type 2 diabetes and DN and 15 healthy controls. Patients were followed for 3 years and the annual percentage change in eGFR was used to estimate the progression of DN. Patients with an annual percentage change in eGFR above the cutoff value of - 5.48%/year were classified in group 1, those with an annual percentage change in eGFR ≤ - 5.48%/year in group 2.
The 28 patients in group 1 had the annual percentage change in eGFR of - 4.78 and 39.12%/year, and for the 17 patients in group 2 it ranged from - 24.86 to - 6.18%/year. At the onset of the study no significant differences were found between the groups in demographic, clinical or laboratory parameters. Plasma activities of glutathione peroxidase (GPX) and superoxide dismutase (SOD) were significantly lower in patients than in the controls. During 3-year study kidney function and size changed insignificantly in group 1, while eGFR and kidney size decreased and proteinuria increased significantly in group 2. Multivariate linear regression analysis selected male gender, duration of diabetes, systolic blood pressure, fasting serum glucose, urine protein/creatinine ratio as factors associated with DN progression. Plasma activity of GPX and SOD were selected as positive predictors of annual percentage change in eGFR.
Besides already known factors, plasma activity of GPX and SOD were found to be significant independent predictors of DN progression.
本研究旨在探讨氧化应激生物标志物是否为糖尿病肾病(DN)进展的预测指标。
该研究纳入了45例2型糖尿病合并DN患者和15例健康对照者。对患者进行了3年的随访,并使用估算肾小球滤过率(eGFR)的年变化百分比来评估DN的进展情况。eGFR年变化百分比高于-5.48%/年临界值的患者被归为第1组,eGFR年变化百分比≤-5.48%/年的患者归为第2组。
第1组的28例患者eGFR的年变化百分比为-4.78%至39.12%/年,第2组的17例患者该指标范围为-24.86%至-6.18%/年。在研究开始时,两组在人口统计学、临床或实验室参数方面未发现显著差异。患者血浆中谷胱甘肽过氧化物酶(GPX)和超氧化物歧化酶(SOD)的活性显著低于对照组。在3年的研究期间,第1组的肾功能和肾脏大小变化不明显,而第2组的eGFR和肾脏大小下降,蛋白尿显著增加。多变量线性回归分析选择男性、糖尿病病程、收缩压、空腹血糖、尿蛋白/肌酐比值作为与DN进展相关的因素。GPX和SOD的血浆活性被选为eGFR年变化百分比的阳性预测指标。
除了已知因素外,还发现GPX和SOD的血浆活性是DN进展的重要独立预测指标。